Quantcast

Latest Osteoarthritis Stories

2014-10-30 12:28:14

- AMAP102 falls short of primary endpoint in exploratory Phase 2a study - GOTHENBURG, Sweden, Oct. 30, 2014 /PRNewswire/ -- AnaMar AB, a Swedish biopharmaceutical company focusing on selective peripheral 5-HT receptor antagonists for debilitating and life-threatening diseases, today announced top-line results from an exploratory Phase 2a double-blind, placebo?controlled, parallel-group, randomized study evaluating the efficacy, safety and tolerability of AMAP102 for the treatment...

2014-10-28 23:02:36

Achieve Clinical Research recently opened up a new clinical trial, and they are looking to enroll individuals who are suffering from clinically relevant arthritis pain. Adults who are experiencing osteoarthritis symptoms of the knee could qualify. Birmingham, AL (PRWEB) October 28, 2014 *To learn more about this osteoarthritis (OA) clinical trial in Birmingham, AL, please check out Achieve Clinical Research on the web (http://www.achieveclinical.com) or contact them directly at (205)...

2014-10-27 04:21:59

CAMBRIDGE, England, and MECHELEN, Belgium, October 27, 2014 /PRNewswire/ -- GBP2.4 million grant awarded by Innovate UK, the UK's innovation agency Calchan Holdings Limited ("the Company"), a UK company focused on the development of novel medicines based on calcium ion channel modulators, and Galapagos NV (Euronext: GLPG), a clinical stage biotech company focused on developing novel mode of action medicines, today announce that they have entered into a research...

2014-10-23 08:35:44

PHOENIX, Oct. 23, 2014 /PRNewswire/ -- Journal of Pragmatic and Observational Research has published a study on multimodal treatment programs for OsteoArthritis of the knee. Arrowhead Health Centers of Arizona is home to the leading multimodal OsteoArthritis treatment program, offering patients an alternative to knee replacement and other invasive surgeries. Logo - http://photos.prnewswire.com/prnh/20141023/153932LOGO The study found that all patients had an increase in function,...

2014-10-20 12:30:31

Canadian golf icon and ALEVE(®) spokesperson encourages Canadians to break free from their pain TORONTO, Oct. 20, 2014 /CNW/ - Eight-time PGA Tour winner Mike Weir was in Toronto today to talk about breaking free from the pain of arthritis. In partnership with ALEVE and The Arthritis Society, Weir shared his own story that took him from the top of his game to one of the most challenging periods of his life. After a 2011 golfing accident led to an elbow injury that later...

2014-10-17 23:02:58

RnRMarketResearch.com adds “Osteoporosis & Osteoarthritis – Pipeline Review, H2 2014” to its store. The report provides an overview of the Osteoporosis’s and Osteoarthritis’s therapeutic pipeline. Dallas, Texas (PRWEB) October 17, 2014 This report provides comprehensive information on the therapeutic development for Osteoarthritis & Osteoporosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route...

2014-10-16 23:04:11

Arthritis has a significant economic impact on our economy, costing $128 billion annually in medical care and indirect expenses, including lost wages and productivity. Arthritis Foundation and Blue Cross Blue Shield of Texas' partnership will aid in the foundation's effort to support those with the more 100 different types of Arthritis. Houston, TX (PRWEB) October 16, 2014 Arthritis has a significant economic impact on our economy, costing $128 billion annually in medical care and...

2014-10-15 12:31:34

NEW YORK, Oct. 15, 2014 /PRNewswire/ -- Mariel Therapeutics, Inc., a clinical stage therapeutic company focusing on Bone Morphogenetic Protein-7 and its application in Osteoarthritis (OA) and Chronic Kidney Disease (CKD), today announced that the U.S. Patent and Trademark Office (USPTO) has issued two new patents related to BMP-7 in OA and CKD. The newly issued patents expand the already large intellectual property estate surrounding BMP-7, which include over 450 issues and pending...

2014-10-09 23:03:58

The North American Arthroscopic Devices market is anticipated to grow due to developments in visualization and monitoring equipment like arthroscopic devices in the region http://www.micromarketmonitor.com/market/north-america-arthroscopic-devices-5209569368.html (PRWEB) October 09, 2014 The North American arthroscopic devices report defines and segments the concerned market in North America with analysis and forecast of revenue. The arthroscopic devices market in North America is...

2014-10-06 23:03:12

The European Arthroscopic Devices market is anticipated to grow, due to increasing use of these devices in joint replacement and spinal surgeries http://www.micromarketmonitor.com/market/europe-arthroscopic-devices-4162004897.html (PRWEB) October 06, 2014 The European arthroscopic devices report defines and segments the concerned market in Europe with analysis and forecast of revenue. The arthroscopic devices market in Europe is estimated to grow to $1,387.8 million by 2018, at a CAGR of...


Word of the Day
maffling
  • To stammer.
  • Present participle of maffle, to stammer.
  • A simpleton.
The word 'maffle' may come from a Dutch word meaning 'to move the jaws' or a French word meaning 'having large cheeks'.